Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-463-5 | CAS number: 646-06-0
Endpoint summary
Administrative data
Description of key information
Two reliable studies were identified on skin irritation and one reliable study was identified on eye irritation, all performed in rabbits. In the repeated dose inhalation studies no irritating effects of 1,3-Dioxolane to the respiratory tract were observed.
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
In a skin irritation study, 1,3-Dioxolane applied under occlusion (during 24h) showed some irritation. Although the score at t=48h is missing, the mean overall irritation score is below the relevant trigger for classification of 2.0 (to be observed with 4h application under semi-occlusion ). Also in a supporting study treatment during 24h with 1,3-Dioxolane did not result in skin irritation. Repeated treatment showed skin irritation after 10 days of treatment, but effects were reversible after 5 days.
In an eye irritation study, 1,3-Dioxolane showed irritating effects on the cornea, iris and conjunctivae. Irritating effects on cornea and conjunctivae were not fully reversible at termination of the study at 72h, and therefore 1,3-Dioxolane is considered to be irritating to eyes.
In repeated dose inhalation studies with 1,3-Dioxolane no irritating effects were observed.
Effects on eye irritation: irritating
Justification for classification or non-classification
1,3-Dioxolane is not irritating to the skin and to the respiratory system. 1,3-Dioxolane is irritating for eyes, leading to classification with R36 and H319 according to DSD and CLP, respectively.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Route: .live2